MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
2.970
-0.060
-1.98%
After Hours: 2.970 0 0.00% 16:10 06/25 EDT
OPEN
3.080
PREV CLOSE
3.030
HIGH
3.180
LOW
2.940
VOLUME
135.13K
TURNOVER
--
52 WEEK HIGH
31.60
52 WEEK LOW
2.600
MARKET CAP
25.84M
P/E (TTM)
-0.1733
1D
5D
1M
3M
1Y
5Y
1D
BriaCell enters MoU with Uneedle for microneedle technology
TipRanks · 13h ago
BriaCell Therapeutics Inks MoU With Uneedle For Continued Use, Commercial Readiness Of Microneedle Technology For Intradermal Administration Of BriaCell’s Bria-IMT
Benzinga · 14h ago
BRIACELL THERAPEUTICS CORP - ENTERS MOU WITH UNEEDLE FOR MICRONEEDLE ADMINISTRATION OF BRIA-IMT
Reuters · 14h ago
BriaCell signs MoU with Uneedle on microneedle delivery for Bria-IMT breast cancer therapy
PUBT · 14h ago
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
Barchart · 19h ago
Weekly Report: what happened at BCTX last week (0615-0619)?
Weekly Report · 3d ago
BriaCell publishes investor presentation on Bria-IMT pivotal Phase 3 metastatic breast cancer program
PUBT · 6d ago
Weekly Report: what happened at BCTX last week (0608-0612)?
Weekly Report · 06/15 09:07
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.